Yongin-si, South Korea

Eunji Choi


Average Co-Inventor Count = 11.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
3 patents (USPTO):

Title: Eunji Choi: Innovator in Cancer Treatment

Introduction

Eunji Choi is a prominent inventor based in Yongin-si, South Korea. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel antibodies.

Latest Patents

Eunji Choi holds three patents, with her latest inventions focusing on an anti-HER2 antibody and a chimeric antigen receptor. These patents relate to a novel anti-HER2 antibody or an antigen-binding fragment that is utilized in the prevention or treatment of cancer. The antibody specifically binds to HER2, which is highly expressed in cancer cells, particularly in breast and gastric cancer. This antibody targets an epitope distinct from the one that trastuzumab binds to, offering a new approach to cancer therapy.

Career Highlights

Eunji Choi is currently associated with Gc Cell Corporation, where she continues her groundbreaking work in cancer research. Her dedication to developing effective treatments has positioned her as a key figure in the biotechnology industry.

Collaborations

Eunji collaborates with notable colleagues, including Jong Seo Lee and Kyu Tae Kim, who contribute to her research efforts and innovations.

Conclusion

Eunji Choi's work in developing novel anti-HER2 antibodies represents a significant advancement in cancer treatment. Her contributions are paving the way for new therapeutic options for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…